ArticleCritical care research and practice2026
Potential Drug-Drug Interactions in Critically Ill Neonates: Association With Clinical Outcomes in a Prospective Cohort.
Article in Critical care research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Neonates admitted to neonatal intensive care units (NICUs) are frequently exposed to multiple medications, increasing the risk of potential drug-drug interactions (pDDIs). However, the clinical impact of these interactions remains poorly understood in this population. This study aimed to evaluate the occurrence of pDDIs in critically ill neonates and their association with clinical outcomes and laboratory parameters. Methods: This prospective cohort study included 365 neonates admitted to a NICU in Brazil between March 2023 and March 2024. Pharmacotherapy was monitored daily for the identification of pDDIs using the UpToDate database. Interactions were grouped according to their potential clinical outcomes and analyzed for their association with clinical and laboratory parameters. The evaluated parameters included heart rate, respiratory rate, blood pressure, creatinine clearance, urine output, and blood urea nitrogen. Results: A total of 255 neonates (69.9%) experienced at least one pDDI, most of which were classified as risk category C (88.0%). The most frequent mechanisms of pDDIs were associated with heart rate changes (27.4%), nephrotoxicity (18.3%), central nervous system (CNS) depression (14.8%), and hypotension (14.8%). Neonates with pDDIs associated with heart rate changes had higher heart rates (158.1 ± 16.7 vs. 148.7 ± 17.0 bpm; Conclusion: pDDIs are frequent in NICUs and are associated with clinically relevant changes, particularly those involving an increased risk of higher heart rates, renal impairment, and hypotension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.